← Browse by Condition
Medical Condition

diagnosis

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for diagnosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — diagnosis Clinical Trials

How many clinical trials are currently recruiting for diagnosis?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for diagnosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for diagnosis?
diagnosis research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a diagnosis clinical trial?
Eligibility criteria for diagnosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Liverpool University Hospitals NHS Foundation Trust 1 trial
University Hospital, Lille 1 trial
Centre Hospitalier Universitaire de Besancon 1 trial
The General Authority for Teaching Hospitals and Institutes 1 trial
CHU de Reims 1 trial

Recruiting Clinical Trials

NCT06025240
Recruiting
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Enrollment
282 pts
Location
United Kingdom
Sponsor
Liverpool University Hospitals...
View Trial →
NCT05779462
Recruiting
ENDOMETRIOSIS - MRI
Enrollment
52 pts
Location
France
Sponsor
University Hospital, Lille
View Trial →
NCT05824442
Recruiting
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
Enrollment
43 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07108725
Recruiting
Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction
Enrollment
100 pts
Location
Egypt
Sponsor
The General Authority for Teac...
View Trial →
NCT06006429
Recruiting
Intraoral Scanners as Periodontal and Dental Pathologies Diagnosis Tools
Enrollment
30 pts
Location
France
Sponsor
CHU de Reims
View Trial →

Related Conditions

kidney transplant (1) renal transplant failure (1) kidney transplant rejection (1) frailty (1) kidney transplant complications (1) transplant dysfunction (1) renal transplant (1) endometriosis (1) mobility limitation (1) magnetic resonance imaging (1) pelvis (1) comparative study (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology